The vision of the Charles Drew University of Medicine and Science (CDU) Research Enterprise is to be a leading national resource for conducting clinical and translational research that produces high-quality, cost-effective and culturally relevant solutions that improve health and wellness in minority and poor populations.
By promoting strategies that create synergy in research teams and between investigators and the community, CDU will create novel best practice solutions to transform the health of underserved communities that can be used as innovative models throughout the nation and the world.
AXIS (Accelerating eXcellence In Science) is the catalyst to implement the CDU research strategic plan. It is the integrated home for clinical and translational research. AXIS houses experienced and dedicated leadership as well as a myriad of clinical and translational, community, training, and technology resources. AXIS also provides excellent research consultation services.
As its cornerstone, AXIS builds multidisciplinary and interdisciplinary collaborations between CDU investigators and community partners. Our team science activities are supported by eleven core functions at CDU: Biomedical Informatics; Community Engagement; Concierge; Clinical and Translational Research Center; Epidemiology and Biostatistics; Evaluation; Innovations and Partnerships; Pilot Program; Regulatory; Research Education and Training; and Technology Core Laboratories.
The overall purpose of AXIS is to better position CDU for conducting clinical and translational research, especially research that is focused on health disparities. The goals are to:
Goal 1: Transform the CDU research enterprise from traditional basic and clinical research domains into a highly integrated clinical and translational research environment by reorganizing research administration, centralizing and enhancing physical and intellectual resources, and promoting participation in the RCMI Translational Research Network (RTRN) and Clinical and Translational Science Institutes (CTSI).
Goal 2: Develop a unique model for community, multidisciplinary, and multi-institutional partnerships that ensures that clinical and translational research yields high-quality, cost-effective health outcomes.
Goal 3: Implement innovative translational research training and career development activities at CDU and in partnership with RTRN that recognize that the interdependence of basic science, clinical discovery, and patient-oriented research will accelerate improved patient outcomes.
If you have feedback about AXIS, click here to leave feedback.